Related Experiment Video
Updated: Feb 27, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Predicting Patient-Specific Radiotherapy Protocols Based on Mathematical Model Choice for Proliferation Saturation
Jan Poleszczuk1,2, Rachel Walker1, Eduardo G Moros3
1Department of Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33647, USA.
The proliferation saturation index (PSI) helps tailor radiotherapy (RT) protocols. However, clinical recommendations strongly depend on the assumed tumor growth law, suggesting its best use when tumor growth is known or multiple models agree.
Area of Science:
- Oncology
- Medical Physics
- Mathematical Biology
Background:
- Radiotherapy (RT) is a cornerstone of cancer treatment, with over 50% of patients receiving it.
- Advances in RT have historically focused on physical aspects, but incorporating tumor biology is a recent development.
- Tumor response to RT depends on the proportion of proliferating and growth-arrested cells.
Purpose of the Study:
- To investigate the impact of different tumor growth laws on clinical recommendations derived from the proliferation saturation index (PSI) framework.
- To evaluate a generalized logistic equation for modeling tumor kinetics and its influence on PSI-based RT protocols.
- To determine the conditions under which the PSI framework is most reliably applied in clinical practice.
Main Methods:
- Applied a generalized logistic equation to model tumor growth kinetics, encompassing logistic and Gompertzian models.
- Estimated model parameters using clinical data to assess the generalized logistic model's fit across various exponent values.
- Analyzed the dependency of clinical RT recommendations on the assumed underlying tumor growth law within the PSI framework.
Main Results:
- The generalized logistic model effectively described clinical data across a wide range of the generalized logistic exponent.
- Clinical recommendations derived from the PSI framework demonstrated significant dependence on the specific tumor growth law assumed.
- Model parameter estimation showed the generalized logistic model's robustness in fitting diverse growth patterns.
Conclusions:
- The PSI framework's clinical utility is maximized when the underlying tumor growth law is known.
- Alternatively, the PSI framework is most reliable when multiple tumor growth models converge on similar RT fractionation protocols.
- Further research is needed to refine the integration of tumor biology into personalized radiotherapy decision-making.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
10:23Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics
Published on: December 1, 2023
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...